| Clock drawing in Alzheimer's disease: a novel measure of dementia severity T Sunderland, JL Hill, AM Mellow, BA Lawlor, J Gundersheimer, ... Journal of the American Geriatrics society 37 (8), 725-729, 1989 | 1637 | 1989 |
| Effects of nicotinic stimulation on cognitive performance PA Newhouse, A Potter, A Singh Current opinion in pharmacology 4 (1), 36-46, 2004 | 560 | 2004 |
| Intravenous nicotine in Alzheimer's disease: a pilot study PA Newhouse, T Sunderland, PN Tariot, CL Blumhardt, H Weingartner, ... Psychopharmacology 95 (2), 171-175, 1988 | 432 | 1988 |
| Cognitive-behavioral therapy increases prefrontal cortex gray matter in patients with chronic pain DA Seminowicz, M Shpaner, ML Keaser, GM Krauthamer, J Mantegna, ... The Journal of Pain 14 (12), 1573-1584, 2013 | 385 | 2013 |
| Estrogen, stress, and depression: cognitive and biological interactions KM Albert, PA Newhouse Annual review of clinical psychology 15 (1), 399-423, 2019 | 380 | 2019 |
| Nicotinic system involvement in Alzheimer’s and Parkinson’s diseases: implications for therapeutics PA Newhouse, A Potter, ED Levin Drugs & aging 11 (3), 206-228, 1997 | 360 | 1997 |
| Alzheimer disease as a clinical-biological construct—an International Working Group recommendation B Dubois, N Villain, L Schneider, N Fox, N Campbell, D Galasko, ... JAMA neurology 81 (12), 1304-1311, 2024 | 302 | 2024 |
| Estradiol levels modulate brain activity and negative responses to psychosocial stress across the menstrual cycle K Albert, J Pruessner, P Newhouse Psychoneuroendocrinology 59, 14-24, 2015 | 296 | 2015 |
| The role of estrogen in brain and cognitive aging JK Russell, CK Jones, PA Newhouse Neurotherapeutics 16 (3), 649-665, 2019 | 284 | 2019 |
| Nicotine treatment of mild cognitive impairment: a 6-month double-blind pilot clinical trial P Newhouse, K Kellar, P Aisen, H White, K Wesnes, E Coderre, A Pfaff, ... Neurology 78 (2), 91-101, 2012 | 284 | 2012 |
| The cholinergic hypothesis of cognitive aging revisited again: cholinergic functional compensation JA Dumas, PA Newhouse Pharmacology Biochemistry and Behavior 99 (2), 254-261, 2011 | 281 | 2011 |
| The effects of nicotine on Parkinson's disease. MC Kelton, HJ Kahn, CL Conrath, PA Newhouse Brain and cognition 43 (1-3), 274-282, 2000 | 278 | 2000 |
| Effects of acute nicotine administration on behavioral inhibition in adolescents with attention-deficit/hyperactivity disorder AS Potter, PA Newhouse Psychopharmacology 176 (2), 183-194, 2004 | 251 | 2004 |
| A new scale for the assessment of depressed mood in demented patients. T Sunderland, IS Alterman, D Yount, JL Hill, PN Tariot, PA Newhouse, ... The American journal of psychiatry 145 (8), 955-959, 1988 | 251 | 1988 |
| L-deprenyl in Alzheimer's disease: preliminary evidence for behavioral change with monoamine oxidase B inhibition PN Tariot, RM Cohen, T Sunderland, PA Newhouse, D Yount, AM Mellow, ... Archives of General Psychiatry 44 (5), 427-433, 1987 | 251 | 1987 |
| Mild cognitive impairment: diagnosis, longitudinal course, and emerging treatments JN Vega, PA Newhouse Current psychiatry reports 16 (10), 490, 2014 | 249 | 2014 |
| A double-blind comparison of sertraline and fluoxetine in depressed elderly outpatients PA Newhouse, KRR Krishnan, PM Doraiswamy, EM Richter, ED Batzar, ... Journal of Clinical Psychiatry 61 (8), 559-568, 2000 | 219 | 2000 |
| Acute nicotine improves cognitive deficits in young adults with attention-deficit/hyperactivity disorder AS Potter, PA Newhouse Pharmacology Biochemistry and Behavior 88 (4), 407-417, 2008 | 210 | 2008 |
| An 8-week multicenter, parallel-group, double-blind, placebo-controlled study of sertraline in elderly outpatients with major depression LS Schneider, JC Nelson, CM Clary, P Newhouse, KRR Krishnan, ... American Journal of Psychiatry 160 (7), 1277-1285, 2003 | 206 | 2003 |
| Acute effects of the selective cholinergic channel activator (nicotinic agonist) ABT-418 in Alzheimer’s disease A Potter, J Corwin, J Lang, M Piasecki, R Lenox, PA Newhouse Psychopharmacology 142 (4), 334-342, 1999 | 202 | 1999 |
